IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FATTIZZO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.911
AS - Asia 12.155
NA - Nord America 11.328
SA - Sud America 1.944
AF - Africa 419
OC - Oceania 147
Continente sconosciuto - Info sul continente non disponibili 12
Totale 42.916
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.362
DE - Germania 8.148
CN - Cina 3.704
SG - Singapore 3.149
IT - Italia 2.602
GB - Regno Unito 1.430
BR - Brasile 1.110
HK - Hong Kong 997
FR - Francia 913
VN - Vietnam 880
IN - India 829
RU - Federazione Russa 754
JP - Giappone 601
ES - Italia 537
SE - Svezia 531
BD - Bangladesh 503
MX - Messico 500
ID - Indonesia 394
CA - Canada 382
NL - Olanda 376
IE - Irlanda 310
TR - Turchia 269
FI - Finlandia 256
AR - Argentina 249
CO - Colombia 210
CH - Svizzera 142
GR - Grecia 136
PL - Polonia 129
AU - Australia 124
KR - Corea 121
CI - Costa d'Avorio 117
CL - Cile 110
BE - Belgio 95
PE - Perù 93
PK - Pakistan 91
DK - Danimarca 81
TH - Thailandia 79
AT - Austria 75
EC - Ecuador 73
UA - Ucraina 70
ZA - Sudafrica 62
SA - Arabia Saudita 61
PT - Portogallo 58
PH - Filippine 57
TW - Taiwan 56
EG - Egitto 55
RO - Romania 52
MY - Malesia 51
IR - Iran 49
IQ - Iraq 44
IL - Israele 41
MA - Marocco 39
DZ - Algeria 38
HR - Croazia 35
NO - Norvegia 35
VE - Venezuela 33
UY - Uruguay 25
AE - Emirati Arabi Uniti 23
BO - Bolivia 23
NZ - Nuova Zelanda 23
TN - Tunisia 23
AL - Albania 21
HU - Ungheria 21
RS - Serbia 21
UZ - Uzbekistan 20
JO - Giordania 19
LB - Libano 18
PY - Paraguay 18
LU - Lussemburgo 14
LT - Lituania 13
OM - Oman 13
CR - Costa Rica 12
NP - Nepal 11
BG - Bulgaria 10
JM - Giamaica 10
KE - Kenya 10
PA - Panama 10
CZ - Repubblica Ceca 9
GT - Guatemala 9
LK - Sri Lanka 9
SI - Slovenia 9
SN - Senegal 9
AO - Angola 8
MN - Mongolia 8
EE - Estonia 7
ET - Etiopia 7
AZ - Azerbaigian 6
CU - Cuba 6
CY - Cipro 6
KW - Kuwait 6
LV - Lettonia 6
LY - Libia 6
MD - Moldavia 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
XK - ???statistics.table.value.countryCode.XK??? 6
GD - Grenada 5
GE - Georgia 5
HN - Honduras 5
MM - Myanmar 5
Totale 42.811
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 6.639
Singapore 1.670
Ashburn 1.135
Hanover 930
Hong Kong 824
Southend 758
Dallas 747
Milan 650
Chandler 585
San Jose 553
Beijing 497
Council Bluffs 442
New York 417
Los Angeles 330
Dublin 301
Princeton 291
Ho Chi Minh City 283
Hefei 271
Fairfield 269
Rome 226
Shanghai 221
Wilmington 216
Hanoi 211
Lauterbourg 195
Santa Clara 195
Bengaluru 192
Helsinki 192
Seattle 190
Jakarta 174
Tokyo 173
Redwood City 167
São Paulo 164
Buffalo 157
Madrid 157
Cambridge 149
Guangzhou 143
Houston 141
Moscow 139
Woodbridge 139
Paris 121
Abidjan 117
Des Moines 116
Toronto 114
Tianjin 111
Ann Arbor 110
Istanbul 103
Hyderabad 102
Buenos Aires 100
London 95
Nanjing 95
Bogotá 91
Chicago 89
Hangzhou 85
Naples 79
Barcelona 78
Mexico City 78
Columbus 75
Berlin 73
Boardman 72
Phoenix 72
Santiago 69
Chennai 68
Manchester 66
Seoul 66
Boston 65
Lima 63
Amsterdam 60
Munich 59
Dearborn 57
Chengdu 56
New Delhi 56
The Dalles 56
Cangzhou 52
Genoa 52
Shenzhen 52
Turin 52
Brussels 49
Zurich 49
Athens 48
Brooklyn 48
Da Nang 48
Rio de Janeiro 48
Jinan 47
Vienna 47
Washington 46
Atlanta 45
Bangkok 45
Bologna 45
Belo Horizonte 44
Duncan 44
Florence 44
Mumbai 44
Warsaw 44
Nuremberg 43
Verona 43
Montreal 41
Memphis 40
Osaka 40
San Diego 40
Bari 39
Totale 25.129
Salva come PNG Salva come JPEG
Nome #
How I treat warm autoimmune hemolytic anemia 4.547
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia : a GIMEMA study of 308 Patients 1.870
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers 1.488
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease : a phase 2 prospective GIMEMA study 700
Anemia emolitica autoimmune dall’approccio classico ai nuovi farmaci 564
Low-dose rituximab in autoimmune hemolytic anemia : 10 years after 499
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy 479
Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome 446
Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias 424
Evidence based use of erytrhopoietin in patients with autoimmune hemolytic anemia: a multicenter international study 416
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag 390
Prognostic and predictive impact of small PNH clones in a large cohort of patients with myelodysplastic syndrome and aplastic anemia: a single-center experience 381
Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy 345
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 332
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia 321
Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag 314
Paroxysmal Nocturnal Hemoglobinuria (Pnh) : Brain Mri Ischemic Lesions in Neurologically Asymtomatic Patients 301
Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues 287
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects 282
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 271
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia 271
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation : current perspectives 251
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature 251
Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late‐stage erythropoiesis 250
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report 250
Evans syndrome in adults : an observational multicenter study 248
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience 247
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs 246
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study 243
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications 240
Complement Mediated Hemolytic Anemias in the COVID-19 Era : Case Series and Review of the Literature 236
Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes : Whoever Seeks Finds 236
Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients 235
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study 233
Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization 231
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study 231
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects 226
Clinical significance of PNH clones in 3085 patients with cytopenia: a large single-center experience 226
The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease 226
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review 224
Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome 224
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia 218
Hypoplastic myelodysplastic syndromes: Just an overlap syndrome? 217
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts 216
Autoimmune hemolytic anemia: clinical severity and laboratory heterogeneity in 157 patients 216
The Changing Landscape of Autoimmune Hemolytic Anemia 215
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study 213
Reduced expression of toll-like receptor 4 in B-chronic lymphocytic leukemia patients with autoimmune complications 211
Brain MRI Findings and Neuro-Psychiatric Involvement in Paroxysmal Nocturnal Hemoglobinuria (PNH) 209
Chronic Idiopathic Neutropenia In Adults: Clinical Features In a 4-Year Prospective Study 208
Impact of bone marrow fibrosis in response to azacitidine in 94 patients with myelodisplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia 207
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias 205
Bortezomib in autoimmune hemolytic anemia and beyond 205
Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations 204
Evidence based use of erytrhopoietin in patients with Autoimmune Hemolytic Anemia : a multicenter international study 204
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia 202
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations 202
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia 201
Neuro-psychiatric involvement in paroxysmal nocturnal hemoglobinuria (PNH) 201
Rise of the planet of rare anemias: An update on emerging treatment strategies 199
Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk 199
Anti-erythroblast autoimmunity in early myelodysplastic syndromes: enhancement of EPO/EPO-R system and PRO-apoptotic effect 198
Three hematologic malignancies in the same patient : chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia 198
Innovative Treatments for Rare Anemias 198
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia 197
Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression 196
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes : a second honeymoon? 196
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers 195
Recent insights into the role of the microbiome in malignant and benign hematologic diseases 195
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome : From Megakaryopoiesis to Immunomodulation 193
Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study 192
Prevalence and clinical significance of small PNH clones in patiens with primary autoimmune hemolytic anemia 192
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia 192
Infectious complications in autoimmune hemolytic anemia 191
Clinical heterogeneity of autoimmune hemolytic anemia: a gimema study of 308 patients 190
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias 189
Inhibition of C3 with APL-2 controls haemolysis and increases haemoglobin levels in subjects with Autoimmune Haemolytic Anaemia (AIHA) 187
Infectious and thrombotic complications and their prognostic impact in patients with concomitant myeloid and lymphoid neoplasms : a single-center cohort study 187
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia 186
Deciphering cytopenias in internal medicine: a single-center observational study 184
25-Oh Vitamin D, Vitamin D Receptor and Immunomodulatory Cytokines Serum Levels in Patients with Autoimmune Citopenias: Correlation with Hematologic Parameters and Clinical Severity 184
Impact of intravascular hemolysis and multitreatment on thrombosis occurrence in autoimmune hemolytic anemia 183
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures 183
Evans syndrome: Disease awareness and clinical management in a nation‐wide ITP‐NET survey 180
Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation 180
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality 180
Clinical follow-up of 378 patients with autoimmune hemolytic anemia: prognostic impact of hemoglobin levels, autoantibody class, and reticulocytopenia at onset on the relapse risk and outcome 177
A case of chronic chronic lymphocytic leukemia developing chronic myeloid leukemia with high platelets and followed by acute myeloid leukemia 176
Difficult cases of paroxysmal nocturnal hemoglobinuria: Diagnosis and therapeutic novelties 175
Myelofibrosis and following chronic myeloid leukemia: imatinib and ruxolitinib treatment in two cases 174
Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature 174
Clinical Heterogeneity Of Autoimmune Hemolytic Anemia: A 35-Years Retrospective Study Of 157 Patients 173
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? 172
Difficult cases of autoimmune hemolytic anemia: A challenge for the internal medicine specialist 172
Autoimmune complications in hematologic neoplasms 170
Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Predictor of Outcome? 169
Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group 169
Idelalisib Rapidly Improves Platelets Function in Patients with Chronic Lymphocytic Leukemia (CLL) 169
Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature 169
Cold agglutinin disease revisited: a multinational, observational study of 232 patients 168
Totale 30.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.854
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 0 0 0 0 0 0 0 0 125 130
2021/20223.631 112 154 299 221 283 200 229 455 468 357 340 513
2022/20234.063 379 310 299 384 294 548 280 301 428 175 395 270
2023/20248.022 266 276 275 323 589 297 1.108 969 580 983 1.247 1.109
2024/20259.443 1.003 1.196 862 959 498 422 415 654 569 656 681 1.528
2025/202615.379 1.413 1.185 1.938 1.452 1.330 896 1.929 826 1.558 1.044 1.808 0
Totale 44.063